Page results
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
EMIS outage caused backlog of result messages via Keystone
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
File results
-
FOI/2024/0750 - Spend on law firms for services related to maternity and neonatal care 2021-2023
-
FOI/2024/0776 - Buildings used by the Trust which still contain asbestos
-
FOI/2024/0814 - Asbestos Compensation 2021/22 - 2023/24
-
FOI/2024/0981 - Asbestos Containing Materials (ACMs)/ asbestos register/ asbestos management
-
UCLH board register of interests
-
UCLH Audit Committee terms of reference
-
-
-
-